FDA seeks input on draft guidance involving device, drug trials

12/12/2012 | Clinica (subscription required)

The FDA has issued draft guidance intended to help institutional review boards, clinical trial sponsors and researchers assess investigator qualifications, decide whether research sites are adequate and determine whether an investigational device exemption or investigational new drug application is necessary to protect human subjects. The guidance is up for comment through Jan. 22.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL